{"id":"W3112058853","doi":"10.1016/j.jval.2020.08.393","title":"PCN256 Health Technology Assessment for Chimeric Antigen Receptor (CAR) T-CELL Therapies for Cancer in Europe, US, and Canada","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Chimeric antigen receptor; Nice; Medicine; Clinical trial; Lymphoma; Cancer; Oncology; Immunotherapy; Intensive care medicine; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01132586,0.0007116327,0.0007403684,0.003675115,0.001679687,0.004364951,0.001575778,0.001740484,0.005867903],"category_scores_gemma":[0.01317965,0.0003169904,0.001653355,0.003755301,0.0007872537,0.0006827199,0.00113155,0.00148995,0.001032754],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.06188728,"about_ca_system_score_gemma":0.2395546,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9414508,"about_ca_topic_score_gemma":0.9376905,"domain_scores_codex":[0.9884486,0.001335451,0.0003311789,0.0004173315,0.007976244,0.001491101],"domain_scores_gemma":[0.9832903,0.001259913,0.0007285527,0.0001590537,0.01193506,0.002627097],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005975043,0.0007315378,0.1006006,0.00261194,0.0008889982,0.0005550389,0.0004085343,0.01332241,0.007594706,0.03608696,0.3905024,0.4407218],"study_design_scores_gemma":[0.0006064654,0.001813295,0.1961798,0.00184679,0.0007665454,0.0002414629,0.000777974,0.005590334,0.006505006,0.002223041,0.7833205,0.0001288099],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"review","genre_scores_codex":[0.1778793,0.06337202,0.01174484,0.08772066,0.003945827,0.005471693,0.1500425,0.0008643071,0.4989589],"genre_scores_gemma":[0.6488966,0.06050846,0.02671296,0.01935636,0.0008254519,0.002494746,0.07254766,0.0003776696,0.1682802],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.06188728,"threshold_uncertainty_score":0.4490258,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06356303064571747,"score_gpt":0.3777604819921875,"score_spread":0.31419745134647,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}